T2	Participants 280 305	children <6 months of age
T3	Participants 660 698	healthy children 6 to <24 weeks of age
T4	Participants 708 763	Healthy infants aged 6 to <16 weeks and 16 to <24 weeks
T1	Participants 27 109	cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age
